IMDCPNI

İbrahim Vedat Bayoğlu1, Javid Hüseynov1, Alper Topal2

  • 1Department of Medical Oncology, School of Medicine, Marmara University, 34899 Istanbul, Turkey.

PubMed
概括

调整后的PNI-IMDC风险评分有助于分层介质转移性细胞癌 (mRCC) 患者接受一线TKIs. 预治疗PNI可以进一步完善预后模型,以改善患者分层.